Compare DRD & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRD | TXG |
|---|---|---|
| Founded | 1895 | 2012 |
| Country | South Africa | United States |
| Employees | 3410 | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.7B |
| IPO Year | N/A | 2019 |
| Metric | DRD | TXG |
|---|---|---|
| Price | $26.51 | $28.26 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 15 |
| Target Price | ★ $32.63 | $20.25 |
| AVG Volume (30 Days) | 232.5K | ★ 2.7M |
| Earning Date | 08-19-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.24% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $39.23 | N/A |
| Revenue Next Year | $30.12 | $7.33 |
| P/E Ratio | $15.32 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $13.08 | $8.95 |
| 52 Week High | $39.37 | $28.17 |
| Indicator | DRD | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 44.11 | 72.87 |
| Support Level | $26.07 | $19.68 |
| Resistance Level | $30.99 | N/A |
| Average True Range (ATR) | 0.91 | 1.59 |
| MACD | -0.05 | 0.68 |
| Stochastic Oscillator | 20.03 | 94.01 |
DRDGold Ltd is a South African gold mining company engaged in surface gold tailings retreatment including exploration, extraction, processing, and smelting. Its reportable operating segments are; Ergo, FWGR, and Corporate office and other reconciling items. The Ergo is a surface gold retreatment operation that treats old slime dams and sand dumps to the south of Johannesburg's central business district as well as the East and Central Rand goldfields, and the FWGR which is a surface gold retreatment operation and treats old slime dams in the West Rand goldfields. The Ergo segment derives a vast majority of the company's revenue.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).